• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肠道微生态:中药治疗高血压的潜在干预策略

Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension.

作者信息

Yang Zhihua, Lin Shanshan, Liu Yangxi, Song Zhihui, Ge Zhao, Fan Yujian, Chen Lu, Bi Yingfei, Zhao Zhiqiang, Wang Xianliang, Wang Yi, Mao Jingyuan

机构信息

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Front Pharmacol. 2023 May 31;14:1171119. doi: 10.3389/fphar.2023.1171119. eCollection 2023.

DOI:10.3389/fphar.2023.1171119
PMID:37324472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10264781/
Abstract

Hypertension has become one of the major public health problems in the world. At present, the pathogenesis of hypertension has still not been completely elucidated. In recent years, an increasing evidence shows that intestinal microecology is closely related to hypertension, which provides a new thinking for the prevention and treatment of hypertension. Traditional Chinese medicine (TCM) has unique advantages in the treatment of hypertension. Taking intestinal microecology as the target, it is possible to interpreting the scientific connotation of TCM prevention and treatment of hypertension by updating the treatment concept of hypertension, so as to improve the therapeutic effect. In our study, the clinical evidence for TCM treatment of hypertension was systematicly summarized. And the relationship among TCM, intestinal microecology and hypertension was analyzed. In addition, the methods by which TCM regulates intestinal microecology to prevent and treat hypertension were presented, to provide new research ideas for prevention and treatment of hypertension.

摘要

高血压已成为全球主要的公共卫生问题之一。目前,高血压的发病机制仍未完全阐明。近年来,越来越多的证据表明肠道微生态与高血压密切相关,这为高血压的防治提供了新的思路。中医在高血压治疗方面具有独特优势。以肠道微生态为靶点,通过更新高血压治疗理念,有可能阐释中医防治高血压的科学内涵,从而提高治疗效果。在我们的研究中,系统总结了中医治疗高血压的临床证据。并分析了中医、肠道微生态与高血压之间的关系。此外,还介绍了中医通过调节肠道微生态防治高血压的方法,为高血压的防治提供新的研究思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/6c4ef05aaaf4/fphar-14-1171119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/20ca45244098/fphar-14-1171119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/8b30ecc90926/fphar-14-1171119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/6c4ef05aaaf4/fphar-14-1171119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/20ca45244098/fphar-14-1171119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/8b30ecc90926/fphar-14-1171119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777e/10264781/6c4ef05aaaf4/fphar-14-1171119-g003.jpg

相似文献

1
Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension.靶向肠道微生态:中药治疗高血压的潜在干预策略
Front Pharmacol. 2023 May 31;14:1171119. doi: 10.3389/fphar.2023.1171119. eCollection 2023.
2
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.中医药:通过肠道微生态调节溃疡性结肠炎细菌菌群失衡、肠屏障损伤及免疫功能紊乱的策略
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116879. doi: 10.1016/j.jep.2023.116879. Epub 2023 Jul 5.
3
An overview of traditional Chinese medicine affecting gut microbiota in obesity.中医对肥胖症中肠道微生物群影响的概述。
Front Endocrinol (Lausanne). 2023 Mar 1;14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023.
4
[Research status on regulation of Chinese herbal compound on intestinal microecology].中药复方对肠道微生态调节的研究现状
Zhongguo Zhong Yao Za Zhi. 2015 Sep;40(18):3534-7.
5
Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.肠道大肠杆菌及相关功能障碍作为中医药治疗呼吸传染性疾病的潜在靶点。
J Ethnopharmacol. 2023 Sep 15;313:116381. doi: 10.1016/j.jep.2023.116381. Epub 2023 Mar 20.
6
Gut microbiota: A new target of traditional Chinese medicine for insomnia.肠道微生物群:中医药治疗失眠的新靶点。
Biomed Pharmacother. 2023 Apr;160:114344. doi: 10.1016/j.biopha.2023.114344. Epub 2023 Feb 2.
7
Probiotic-fermented traditional Chinese herbal medicine, a promising approach to maintaining the intestinal microecology.益生菌发酵中药,一种维持肠道微生态的有前景的方法。
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118815. doi: 10.1016/j.jep.2024.118815. Epub 2024 Sep 11.
8
Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?肠道微生物群与心脏之间的相互作用:草药治疗心力衰竭的新靶点?
Evid Based Complement Alternat Med. 2020 Apr 6;2020:9097821. doi: 10.1155/2020/9097821. eCollection 2020.
9
Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota.通过中医药防治慢性心力衰竭:肠道微生物群的作用。
Pharmacol Res. 2020 Jan;151:104552. doi: 10.1016/j.phrs.2019.104552. Epub 2019 Nov 17.
10
Association of lung-intestinal microecology and lung cancer therapy.肺-肠道微生态与肺癌治疗的关联
Chin Med. 2023 Apr 10;18(1):37. doi: 10.1186/s13020-023-00742-8.

引用本文的文献

1
Gut Microbiota and Cardiovascular Diseases: Unraveling the Role of Dysbiosis and Microbial Metabolites.肠道微生物群与心血管疾病:揭示生态失调和微生物代谢产物的作用
Int J Mol Sci. 2025 Apr 30;26(9):4264. doi: 10.3390/ijms26094264.
2
Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced therapeutic potential.探索与高血压相关的疾病:对具有增强治疗潜力的创新药物组合的全面综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 31. doi: 10.1007/s00210-025-03819-3.
3
Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension.

本文引用的文献

1
Gut microbiota and hypertension: association, mechanisms and treatment.肠道微生物群与高血压:关联、机制与治疗。
Clin Exp Hypertens. 2023 Dec 31;45(1):2195135. doi: 10.1080/10641963.2023.2195135.
2
Gut microbiota: A new target of traditional Chinese medicine for insomnia.肠道微生物群:中医药治疗失眠的新靶点。
Biomed Pharmacother. 2023 Apr;160:114344. doi: 10.1016/j.biopha.2023.114344. Epub 2023 Feb 2.
3
Chai-Gui Decoction and its representative components ameliorate spontaneous hypertension rats by modulating lipid metabolism and gut microbiota.
中药调节肠道菌群治疗高血压的研究进展
Front Pharmacol. 2024 Dec 9;15:1449972. doi: 10.3389/fphar.2024.1449972. eCollection 2024.
4
Targeting the neurovascular unit: Therapeutic potential of traditional Chinese medicine for the treatment of stroke.靶向神经血管单元:中药治疗中风的潜在疗效
Heliyon. 2024 Sep 20;10(19):e38200. doi: 10.1016/j.heliyon.2024.e38200. eCollection 2024 Oct 15.
5
Puerarin Alleviates Blood Pressure via Inhibition of ROS/TLR4/NLRP3 Inflammasome Signaling Pathway in the Hypothalamic Paraventricular Nucleus of Salt-Induced Prehypertensive Rats.葛根素通过抑制盐诱导的高血压前期大鼠下丘脑室旁核中的 ROS/TLR4/NLRP3 炎性体信号通路来降低血压。
Nutrients. 2024 Aug 6;16(16):2580. doi: 10.3390/nu16162580.
6
Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE Mice.健脾化瘀方通过改善炎症和重塑载脂蛋白 E 小鼠的肠道微生物群来预防动脉粥样硬化。
Cell Biochem Biophys. 2024 Sep;82(3):2297-2319. doi: 10.1007/s12013-024-01341-6. Epub 2024 Aug 22.
7
Gut microbiota: a potential new regulator of hypertension.肠道微生物群:高血压的一种潜在新调节因子。
Front Cardiovasc Med. 2024 Jun 27;11:1333005. doi: 10.3389/fcvm.2024.1333005. eCollection 2024.
柴胡桂枝汤及其代表性成分通过调节脂质代谢和肠道微生物群改善自发性高血压大鼠。
J Ethnopharmacol. 2023 Apr 6;305:116116. doi: 10.1016/j.jep.2022.116116. Epub 2023 Jan 2.
4
A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization.中医治疗溃疡性结肠炎的一个潜在治疗靶点:巨噬细胞极化。
Front Pharmacol. 2022 Sep 6;13:999179. doi: 10.3389/fphar.2022.999179. eCollection 2022.
5
Traditional Chinese medicine against COVID-19: Role of the gut microbiota.中医药防治 COVID-19:肠道微生物群的作用。
Biomed Pharmacother. 2022 May;149:112787. doi: 10.1016/j.biopha.2022.112787. Epub 2022 Mar 8.
6
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.中药与氯沙坦治疗轻中度原发性高血压的疗效和安全性比较:一项随机、多中心、双盲、非劣效性试验。
Circ Cardiovasc Qual Outcomes. 2022 Mar;15(3):e007923. doi: 10.1161/CIRCOUTCOMES.121.007923. Epub 2022 Feb 2.
7
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment.肠道微生物衍生的短链脂肪酸与高血压:机制与治疗。
Biomed Pharmacother. 2020 Oct;130:110503. doi: 10.1016/j.biopha.2020.110503. Epub 2020 Aug 18.
8
Risk Factors for Intestinal Barrier Impairment in Patients With Essential Hypertension.原发性高血压患者肠道屏障损伤的危险因素
Front Med (Lausanne). 2021 Jan 27;7:543698. doi: 10.3389/fmed.2020.543698. eCollection 2020.
9
New species of Eaton (Diptera, Chironomidae) from China and synonymy of Tokunaga, 1940.来自中国的伊顿摇蚊属(双翅目,摇蚊科)新物种及德永(1940年)的同物异名
Zookeys. 2021 Jan 18;1011:51-61. doi: 10.3897/zookeys.1011.58993. eCollection 2021.
10
Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.肠道微生物群及其代谢产物在动脉粥样硬化、高血压和人类血小板功能中的作用:综述。
Nutrients. 2021 Jan 3;13(1):144. doi: 10.3390/nu13010144.